STOCK TITAN

Gabelli Healthcare & WellnessRx Trust (GRX) SEC Filings, Mar-Sep 2026

GRX NYSE
Rhea-AI Summary

Gabelli Healthcare & WellnessRx Trust (GRX) reported that major shareholder Saba Capital Management, L.P., a ten percent owner, purchased 500 shares of common stock on September 3, 2026, at $10.08 per share in an open-market or private transaction, held indirectly. Following this trade, Saba Capital’s reported indirect holdings rose to 2,155,633 shares. No Rule 10b5-1 trading plan is reported for this transaction.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.00%
Tags
insider
-
Rhea-AI Summary

Gabelli Healthcare & WellnessRx Trust (GRX) received an amended Schedule 13D (Amendment No. 4) reporting that Saba Capital Management, L.P., Saba Capital Management GP, LLC and Boaz R. Weinstein (together, the reporting persons) beneficially own 2,155,133 common shares of GRX. This represents 14.32% of GRX’s common shares, based on 15,050,683 shares outstanding as of 12/31/25 as disclosed in GRX’s N-CSR filed 3/9/26. The reporting persons hold shared voting and shared dispositive power over all of these shares and no sole power. Approximately $20,771,553 in aggregate was paid to acquire the reported shares, funded by investor subscription proceeds, capital appreciation, and ordinary-course margin borrowings. All transactions in the past 60 days before August 27, 2026 were executed in the open market and are detailed in an attached schedule.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.10%
Tags
ownership
-
Rhea-AI Summary

Gabelli Healthcare & WellnessRx Trust (GRX) reported that Saba Capital Management, L.P., a ten percent owner, purchased 4,340 shares of common stock on August 27, 2026, in an open-market or private transaction at $10.05 per share. Following this indirect ownership purchase, Saba Capital Management reports holding 2,155,133 common shares of GRX.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.10%
Tags
insider
Rhea-AI Summary

Gabelli Healthcare & WellnessRx Trust (GRX) reported that Saba Capital Management, L.P., a ten percent owner, purchased 7,087 shares of Common Stock in an open-market or private transaction on 2026-08-21 at $10.13 per share. After this transaction, Saba Capital Management, L.P. indirectly holds 2,150,793 shares of GRX Common Stock.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.10%
Tags
insider
-
Rhea-AI Summary

Gabelli Healthcare & WellnessRx Trust (GRX) had a Form 4 filed reporting that Saba Capital Management, L.P., a ten percent owner, purchased 24,102 shares of GRX common stock on 2026-08-19 at $10.13 per share in an open-market or private transaction. Following this buy, Saba’s indirectly held position is reported as 2,143,706 shares. The Rule 10b5-1 checkbox was not marked, indicating the trade was not reported as pursuant to a pre-arranged trading plan.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.18%
Tags
insider
-
Rhea-AI Summary

Gabelli Healthcare & WellnessRx Trust reported that Christopher J. Jackson, who serves as Secretary, filed an initial statement of beneficial ownership of securities. The filing does not list any reportable transactions or holdings, indicating this is an administrative Form 3 establishing his insider reporting status.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.35%
Tags
insider
Rhea-AI Summary

Saba Capital Management, L.P., a ten percent owner of Gabelli Healthcare & WellnessRx Trust (GRX), reported a purchase of common stock. On 2026-08-14 it bought 1,203 shares at $9.86 per share in an open market or private transaction, bringing its reported indirect holdings to 2,119,604 shares.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.35%
Tags
insider
-
Rhea-AI Summary

Saba Capital Management, L.P., a ten percent owner of Gabelli Healthcare & WellnessRx Trust (GRX), reported purchasing 200 shares of common stock on 2026-08-11 at $9.93 per share in an open market or private transaction. Following this indirect acquisition, Saba Capital’s reported holdings increased to 2,118,401 shares of GRX common stock.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.10%
Tags
insider
-
Rhea-AI Summary

The Gabelli Healthcare & WellnessRx Trust reported a leadership update following a medical incident involving Trustee and Chief Investment Officer Mario J. Gabelli, who was hospitalized on March 19, 2026 and is recovering, though his return date is unknown. GAMCO’s long-standing succession plan was implemented on March 22, 2026, naming Christopher J. Marangi as President of GAMCO. Day-to-day operations of GAMCO will continue to be led by co-CEO Douglas R. Jamieson and Mr. Marangi, while Gabelli Value team Co-Chief Investment Officers Kevin V. Dreyer and Mr. Marangi lead the Fund’s portfolio management during Mr. Gabelli’s absence.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.22%
Tags
current report
Rhea-AI Summary

The Gabelli Healthcare & WellnessRx Trust is holding its annual shareholder meeting on May 11, 2026, in Greenwich, Connecticut to elect four trustees. Common and preferred shareholders vote together to elect Mario J. Gabelli, Agnes Mullady and Anthonie C. van Ekris, while preferred shareholders separately elect Vincent D. Enright.

Shareholders of record at the close of business on March 12, 2026 may vote by mail, telephone or Internet, and a quorum requires one‑third of outstanding shares. Large holders include Saba Capital with 14.3% of common shares and GAMCO Investors and affiliates with 77.8% of preferred shares.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.80%
Tags
proxy

FAQ

How many Gabelli Healthcare & WellnessRx Trust (GRX) SEC filings are available on StockTitan?

StockTitan tracks 57 SEC filings for Gabelli Healthcare & WellnessRx Trust (GRX). Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for Gabelli Healthcare & WellnessRx Trust (GRX)?

The most recent SEC filing for Gabelli Healthcare & WellnessRx Trust (GRX) was filed on November 19, 2026.